Showing results (301-310 of 1,344) with videos related to
Sort By:
Pageof 135
Practical Neurology|July 3, 2021
Progressive supranuclear palsy: diagnosis and managementJames B Rowe, Negin Holland, Timothy RittmanThe Journal of Antimicrobial Chemotherapy|January 1, 1996
Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994J A Frost, A Kelleher, B RoweJournal of Clinical Microbiology|July 1, 1993
Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157A Thomas, H R Smith, B RoweJournal of Clinical Pathology|October 1, 1977
Incidence of K1 antigen in Escherichia coli isolated from blood and cerebrospinal fluid of patients in the United KingdomT Cheasty, R J Gross, B RoweBrain Communications|September 4, 2025
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?Robert Durcan, Claire O'Callaghan, James B RoweAnnales De Microbiologie|August 1, 1979
[Supplement No XXII (1978) to Kauffmann-White scheme (author's transl)]L Le Minor, J Bockemühl, B RoweFEMS Microbiology Letters|July 1, 1990
The invasiveness of different strains of Salmonella enteritidis phage type 4 for young chickensM Hinton, E J Threlfall, B RoweJournal of Clinical Microbiology|December 1, 1977
Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coliR J Gross, T Cheasty, B RoweAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 21, 2025
Beyond prion-like spreading in neurodegenerative diseaseGeorg Meisl, James B Rowe, David KlenermanEuropean Journal of Epidemiology|January 18, 2003
Characterisation of strains of enteroaggregative Escherichia coli isolated during the infectious intestinal disease study in EnglandA Wilson, J Evans, H Chart, et al.Pageof 135